IL6 and rheumatoid arthritis: Moreover, a very recent study reported that LRG1 was correlated with C-reaction protein (CRP), erythrocyte sedimentation rate (ESR), and traditional biomarkers in RA patients receiving IL-6 inhibitor, which remained elevated despite suppression of CRP and ESR, indicating it might serve as an alternative disease activity biomarker for RA [24].